Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 491 of 1,261
  1. US 10323085

    Methods of treating fibromyalgia

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  2. US 10323083

    Agents that specifically bind matrilin-3 and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  3. US 10323070

    VMP-like sequences of pathogenic Borrelia species and strains

    The Board of Regents of the University of Texas System · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  4. US 10323069

    Senecavirus A antigens and methods of use

    Regents of the University of Minnesota · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  5. US 10323034

    Octahydro fused azadecalin glucocorticoid receptor modulators

    Corcept Therapeutics Incorporated · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  6. US 10323026

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  7. US 10322184

    Emulsions for intrapulmonary delivery

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  8. US 10323061

    Heteroaryl containing bile acid analogs as FXR/TGR5 agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  9. US 10322213

    Compositions and methods for altering the rate of hydrolysis of cured oil-based materials

    ATRIUM MEDICAL CORPORATION · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  10. US 10322171

    Vaccine with reduced enhancement of viral infection

    The Board of Regents of the University of Texas System · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  11. US 10322168

    High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same

    Amphastar Pharmaceuticals, Inc. · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  12. US 10322167

    Method of delivering gonadotropin releasing hormone or an analogue thereof into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  13. US 10322161

    EPHA4 cyclic peptide antagonists for neuroprotection and neural repair

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  14. US 10322181

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  15. US 10322124

    6-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseases

    Sulfateq B.V. · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  16. US 10322129

    Therapeutic compositions containing dipyridamole, treatment packs and kits including such compositions and methods for producing same

    O.D. Ocular Discovery Ltd. · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  17. US 10322118

    Compounds and methods for inhibiting Cif virulence factor

    THE REGENTS OF TE UNIVERSITY OF CALIFORNIA · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  18. US 10322107

    N-methyl-N-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives agonists for the kappa opioid receptor

    Nektar Therapeutics · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  19. US 10321689

    Antimicrobial traditional Chinese medicine composition, and preparation method and use thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  20. US 10322099

    Process to prepare treprostinil, the active ingredient in remodulin®

    United Therapeutics Corporation · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  21. US 10322094

    Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride

    TONIX PHARMA LIMITED · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  22. US 10322069

    Restorative resin compositions and methods of use

    The Board of Regents of the University of Texas System · Granted Jun 18, 2019 · Expires Jun 13, 2039

    granted
  23. CA 3082337

    INHIBITEURS DE DOPAMINE-B-HYDROXYLASE

    BIAL PORTELA & CA SA [PT] · Granted Jun 13, 2019 · Expires Jun 8, 2039

    granted
  24. US 10314904

    Methods for enhancing efficacy of a vaccine by administering an IL-4R antagonist

    REGENERON PHARMACEUTICALS, INC. · Granted Jun 11, 2019 · Expires Jun 6, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.